Search

Your search keyword '"Bujanda, Luis"' showing total 1,870 results

Search Constraints

Start Over You searched for: Author "Bujanda, Luis" Remove constraint Author: "Bujanda, Luis"
1,870 results on '"Bujanda, Luis"'

Search Results

1. CTNND1 is involved in germline predisposition to early-onset gastric cancer by affecting cell-to-cell interactions

2. A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death

4. Stratified analyses refine association between TLR7 rare variants and severe COVID-19

6. Author Correction: Comparison of the management of Helicobacter pylori infection between the older and younger European populations

7. Comparison of the management of Helicobacter pylori infection between the older and younger European populations

9. Combining Asian and European genome-wide association studies of colorectal cancer improves risk prediction across racial and ethnic populations

13. Uso de paneles de genes en pacientes con alto riesgo de cáncer digestivo hereditario: documento de posicionamiento de la AEG, SEOM, AEGH y consorcio IMPaCT-GENÓMICA

15. Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA

17. Screening uptake of colonoscopy versus fecal immunochemical testing in first-degree relatives of patients with non-syndromic colorectal cancer: A multicenter, open-label, parallel-group, randomized trial (ParCoFit study)

19. BMPR2 as a Novel Predisposition Gene for Hereditary Colorectal Polyposis

20. I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease

21. Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis and prognostication of cholangiocarcinoma

23. WED-271 Circulating vesicle microRNAs for metabolic dysfunction-associated steatotic liver disease (MASLD) staging and progression towards liver cancer

24. THU-210 Dysfunctional activation of the DNA damage response is associated with MASLD progression through an E2F2-dependent mechanism

25. Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn's disease: The HEAL study from GETECCU

26. OS-076-YI Bile extracellular vesicles hold protein biomarkers for the early diagnosis of cholangiocarcinoma in individuals with primary sclerosing cholangitis

27. OS-101-YI Remodelling of hepatocyte cholesterol metabolism mediates colorectal liver metastasis

28. OS-042-YI Metabolic reprogramming induced by pravastatin prevents polycystic liver disease progression improving mitochondrial bioenergetics in cystic cholangiocytes

29. Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA

30. SEX-RELATED DIFFERENCES IN THE PHENOTYPE AND COURSE OF INFLAMMATORY BOWEL DISEASE: SEXEII STUDY OF ENEIDA.

32. Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg)

34. TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammation

35. Increased Prevalence of Rare Sucrase-isomaltase Pathogenic Variants in Irritable Bowel Syndrome Patients

39. A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death

40. Quality of Colonoscopy Is Associated With Adenoma Detection and Postcolonoscopy Colorectal Cancer Prevention in Lynch Syndrome

42. Female-Specific Association Between Variants on Chromosome 9 and Self-Reported Diagnosis of Irritable Bowel Syndrome

43. Relationship between IGF-1 and body weight in inflammatory bowel diseases: Cellular and molecular mechanisms involved

44. Effectiveness and safety of a third‐line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study)

45. Effectiveness of Helicobacter pylori Treatments According to Antibiotic Resistance

46. Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry

50. Risk of Colorectal Cancer and Advanced Polyps One Year After Excision of High-Risk Adenomas

Catalog

Books, media, physical & digital resources